Evidence map›Paper›PMID 26750603›Full record

ArticlePerspectives in biology and medicine2015

Immune Cell Identity: Perspective from a Palimpsest.

Ellen V Rothenberg

Abstract read
In one paragraph

Article in Perspectives in biology and medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ellen V Rothenberg

Funding

LINEAGE COMMITMENT MECHANISMS IN LYMPHOID PRECURSORSR01CA090233 · NCI · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ROTHENBERG, ELLEN V. · 2001 to 2011
$3.9M
GATA-3 in precursor commitment to the T lineageR01CA098925 · NCI · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ROTHENBERG, ELLEN V. · 2003 to 2007
$1.8M
LINEAGE ANALYSIS OF FUNCTION IN MURINE LYMPHOCYTESR01AG013108 · NIA · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ROTHENBERG, ELLEN V. · 1995 to 2004
$1.6M
Reverse engineering genetic network architecture of stem-cell/lymphocyte transitiR33HL089123 · NHLBI · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ROTHENBERG, ELLEN V. · 2007 to 2009
$1.6M
Dynamic Epigenetic Mapping of a Stem Cell Differentiation ChoiceRC2CA148278 · NCI · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ROTHENBERG, ELLEN V., WOLD, BARBARA J · 2009 to 2010
$1.6M
NCI NIH HHS R01 CA090233NCI NIH HHS R01 CA098925NCI NIH HHS RC2 CA148278NHLBI NIH HHS R33 HL089123NIA NIH HHS R01 AG013108
6 · The paper itself

Abstract

The immune system in mammals is composed of multiple different immune cell types that migrate through the body and are made continuously throughout life. Lymphocytes and myeloid cells interact with each other and depend upon each other, but each are highly diverse and specialized for different roles. Lymphocytes uniquely require developmentally programmed mutational changes in the genome itself for their maturation. Despite profound differences between their mechanisms of threat recognition and threat response, however, the developmental origins of lymphocytes and myeloid cells are interlinked, and important aspects of their response mechanisms remain shared. It is notable that the chain of logic toward our current understanding of the immune defense system over the past 50 years has been driven by strongly posited models that have led to crucial discoveries, even though these models ended up being partly wrong. The predictive strength of these models and their success as guides to incisive experimental research have illuminated the limits of each model's explanatory scope, beyond which another model needed to assume the lead. This brief review describes how a succession of distinct paradigms has helped to clarify a sophisticated picture of immune cell generation and control.

Indexed as

Adaptive ImmunityAnimalsAutoimmunityClonal Selection, Antigen-MediatedHumansImmune SystemImmune ToleranceImmunity, InnateLymphocytesModels, ImmunologicalMyeloid CellsPhenotypeSignal Transduction

Identifiers

PMID26750603
PMCPMC4747652

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.